Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, ...

Cormorant Asset Management added 251,600 shares in Rapport Therapeutics; the reported position value increased by ...

MOG antibody-associated disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients ...

Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional ...

Chronic sleep deprivation acts as a systemic stressor, elevating risks for cardiovascular disease and metabolic dysregulation while impairing cognitive function.

After the first live implementation phase, Neuraxpharm shared that internal demand forecasts—previously exchanged manually—are now automatically transferred to the CMO's ERP system within minutes of ...

For decades, schizophrenia and bipolar disorder have been diagnosed from the outside in, through behavior, mood, and memory ...

In a separate regulatory disclosure, Granules India announced its Hyderabad unit received a USFDA form 483 with five observations.The inspection conducted from 15th to 19th December 2025 has concluded ...

Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission of brilaroxazine for the ...

ME/CFS is a neurological condition characterized by malaise. Diagnosis requires ruling out other systemic illnesses.

Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Fund” third-quarter 2025 investor letter ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...